MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis.

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Abstract Text:

Cynthia Darlington,Cynthia Darlington,

BioMS Medical Corp, under license from the University of Alberta, is developing MBP-8298, a synthetic peptide analog of myelin basic protein, for the potential treatment of multiple sclerosis. Phase II and III clinical trials of MBP-8298 are underway.

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Publishing Authors By Initials

C Darlington,C Darlington,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current opinion in molecular therapeutics

VOLUME: 9

Page Numbers: 398-402

Journal Abbreviation: Curr. Opin. Mol. Ther.

ISSN: 1464-8431

DAY: 13

MONTH: Aug

YEAR: 2007

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100891485

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis.

AFFILIATION: University of Otago, Department of Pharmacology and Toxicology, School of Medical Science, PO Box 913, Dunedin, New Zealand. cynthia.darlington@stonebow.otago.ac.nz

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Mol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis Related Publications

• Adenosine and cytokine levels following treatment of rheumatoid arthritis with dipyridamole.
• Alterations in xenobiotic metabolism in the long-lived Little mice.
• Blood and speech.
• Comparative field performance over 3 years and two sites of transgenic wheat lines expressing HMW subunit transgenes.
• Cytosolic glucocorticoid receptor expression in the rat vestibular nucleus and hippocampus following unilateral vestibular deafferentation.
• Effects of intra-vestibular nucleus injection of the group I metabotropic glutamate receptor antagonist AIDA on vestibular compensation in guinea pigs.
• Genetic particles.
• Glutamate receptor subunits expression in memory-associated brain structures: Regional variations and effects of aging.
• Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.
• Lymphoid neogenesis and immune infiltration in aged liver.
• MBP-8298, a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis.
• Medical history, sexual, and maturational factors and prostate cancer risk.
• Oral tumors.
• Osteonecrosis at multiple sites in a patient with systemic lupus erythematosus.
• Overview of research on health-related quality of life in patients with chronic liver disease.
• Quantitative changes in gene expression of glutamate receptor subunits/subtypes in the vestibular nucleus, inferior olive and flocculus before and following unilateral labyrinthectomy in the rat: real-time quantitative PCR method.
• Reproductive versatility in Rubus; raspberry-blackberry hybrids; on an integrated species difference.
• The changing face of insulin receptors.
• The contribution of nitric oxide to vestibular compensation: are there species differences?
• The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
• The geographical distribution of cold-blooded vertebrates.
• The geographical distribution of cold-blooded vertebrates.
• The plasmagene theory of the origin of cancer.
• The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain.
• Threat of disease in tropical crops.
• Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.
• Tryptophan, adenosine, neurodegeneration and neuroprotection.